Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum.
about
Surface architecture of histoplasma capsulatumAdaptive immunity to fungiMonoclonal antibody-based therapies for microbial diseasesAntibodies and tuberculosisThe human mycobiome in health and diseaseHistoplasma capsulatum heat-shock 60 orchestrates the adaptation of the fungus to temperature stressBiological function and molecular mapping of M antigen in yeast phase of Histoplasma capsulatum.Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cellsA histoplasma capsulatum-specific IgG1 isotype monoclonal antibody, H1C, to a 70-kilodalton cell surface protein is not protective in murine histoplasmosis.Paracoccidioides brasiliensis enolase is a surface protein that binds plasminogen and mediates interaction of yeast forms with host cells.Calnexin induces expansion of antigen-specific CD4(+) T cells that confer immunity to fungal ascomycetes via conserved epitopes.Agglutination of Histoplasma capsulatum by IgG monoclonal antibodies against Hsp60 impacts macrophage effector functionsIn pulmonary paracoccidioidomycosis IL-10 deficiency leads to increased immunity and regressive infection without enhancing tissue pathology.Adaptive immunity to fungi.Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.Histoplasma mechanisms of pathogenesis--one portfolio doesn't fit all.Antibody therapy for histoplasmosis.Vesicle and vesicle-free extracellular proteome of Paracoccidioides brasiliensis: comparative analysis with other pathogenic fungi.Immunoglobulins G, M, and A against Sporothrix schenckii exoantigens in patients with sporotrichosis before and during treatment with itraconazole.B cells and antibodies in the defense against Mycobacterium tuberculosis infectionThe potential of antibody-mediated immunity in the defence against biological weapons.Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infectionAdvances in combating fungal diseases: vaccines on the thresholdProtective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.Enhanced virulence of Histoplasma capsulatum through transfer and surface incorporation of glycans from Cryptococcus neoformans during co-infection.A new synthesis for antibody-mediated immunity.Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma.Antibody Binding Alters the Characteristics and Contents of Extracellular Vesicles Released by Histoplasma capsulatum.Antibody-mediated immunity against tuberculosis: implications for vaccine developmentMonoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum.Radioimmunotherapy of infectious diseasesHistoplasma capsulatum at the host-pathogen interfaceIFNγ is Required for Optimal Antibody-Mediated Immunity against Genital Chlamydia Infection.Characterization of the Histoplasma capsulatum-induced granuloma.Vaccines under study: non-HIV vaccines.Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens.Potential of anti-Candida antibodies in immunoprophylaxis.Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases.Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections.Where do they come from and where do they go: candidates for regulating extracellular vesicle formation in fungi.
P2860
Q21131150-5DB31D7C-68D7-4C4E-AAD5-834E1E3DD5A8Q27025806-C22F7EB8-6C84-43BF-ACB4-C3B6DCB1E9ECQ27490830-E43AF948-06FC-4354-A55B-8C726E9F8A2FQ28067735-4FF00F03-14D7-4BF3-B799-658F97CCD8D3Q28295636-24209A65-2204-4685-B6CA-49FEC9679C00Q28477126-140F1287-BFC8-416D-8D69-5C635368D939Q33377457-4B0038C4-D33E-4D34-BD53-7B1C60CF2808Q33793546-2DE7945F-CA0E-45CB-AC19-DC43D8A6E4B8Q33962651-44A66998-454C-45D4-98AD-F505A2149E10Q34119378-E40C72FB-1319-4244-A218-1F42ECE22D2AQ34468247-9F21C8A6-B6F9-429A-9DBF-2C5D64E3871AQ34529388-449F002F-00AE-4743-8F44-7E2BDDA83034Q35037044-BA8F02FA-F2B8-4CC2-A02F-5A41EEF4C166Q35164257-99B692DC-E19A-4CBF-A325-CF5B03A830B0Q35164284-BD4AC0E6-D14E-43D0-BE53-DFEFE2A92163Q35585157-7FF245E0-BE97-471F-AB2C-6E5CD0448928Q35724334-0A93D096-6368-4A14-868D-E4ECE11C2342Q35869182-A3992187-586A-456C-B838-5FAB5CF12994Q36095151-20AC1A82-578E-40B9-BE84-6C42DF79EED7Q36238031-D91AD786-3E12-4E62-B5C4-D394168C2252Q36273411-DBEDD038-19AA-4843-98A8-810CEBA75D34Q36313467-2CC3F688-709B-4FA0-AB1E-7958F3213E22Q36406460-6897167B-055E-495A-9688-E7BFB41CA397Q36446429-3921F85D-DC95-4833-9DD0-881B82A17B6CQ36610943-ED9829B5-F2BF-4A1D-858E-9923C15610FEQ36660720-D588A240-94DB-40E0-9C7C-6A12CC648087Q36914682-3ECD0A01-8901-4C02-A171-D30FA1D46C9DQ36973170-6E0F275C-35EA-4B7B-9462-B272459909D2Q37137882-C4B36FF3-5247-4355-8D4A-FF00C8FFF689Q37144958-EB2E4F2E-95C9-46FD-97E5-FAE1408BD4C6Q37178873-94E10665-F4B1-4BE2-8930-1812AC037EAEQ37232212-B1B6088A-44CF-480F-8EBE-0BFBF7D0BC7DQ37345928-40520FE9-FE08-4100-B7B0-6DD22BD2FFC7Q37357512-CA73C7DD-1DCF-46B7-84DF-DE4BC92B7234Q37428016-1D2D4296-FEDD-4FCF-9D6D-C79ABD5CD2D7Q37683238-085C0171-B8F8-4695-A720-80CF529F35D4Q37773252-8C1DD09E-0AFC-40BE-BB49-CC29B0011737Q38011299-420E9F55-4DB1-4790-AE2A-DEE653B36B05Q38067451-B86FFC34-0C10-40CB-AB13-8464175FCEF1Q38104257-B6EA0009-9A29-4A38-BB17-71A4D7B7B794
P2860
Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum.
@ast
Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum.
@en
type
label
Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum.
@ast
Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum.
@en
prefLabel
Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum.
@ast
Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum.
@en
P2093
P2860
P356
P1476
Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum.
@en
P2093
George S Deepe
Joshua D Nosanchuk
Judith N Steenbergen
P2860
P304
P356
10.1172/JCI19361
P407
P577
2003-10-01T00:00:00Z